X4 Pharmaceuticals Inc (XFOR)
0.9891
-0.03
(-3.03%)
USD |
NASDAQ |
Jun 17, 16:00
0.9891
0.00 (0.00%)
After-Hours: 18:53
X4 Pharmaceuticals Free Cash Flow: -103.71M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -103.71M |
December 31, 2023 | -96.57M |
September 30, 2023 | -87.92M |
June 30, 2023 | -86.40M |
March 31, 2023 | -83.48M |
December 31, 2022 | -77.20M |
September 30, 2022 | -77.14M |
June 30, 2022 | -72.06M |
March 31, 2022 | -72.83M |
December 31, 2021 | -71.52M |
September 30, 2021 | -70.26M |
June 30, 2021 | -70.85M |
March 31, 2021 | -63.04M |
Date | Value |
---|---|
December 31, 2020 | -60.18M |
September 30, 2020 | -51.70M |
June 30, 2020 | -49.73M |
March 31, 2020 | -52.56M |
December 31, 2019 | -48.23M |
September 30, 2019 | -30.47M |
June 30, 2019 | -25.79M |
March 31, 2019 | -24.99M |
December 31, 2018 | -25.42M |
September 30, 2018 | -46.74M |
June 30, 2018 | -43.68M |
March 31, 2018 | -36.56M |
December 31, 2017 | -27.91M |
Free Cash Flow Range, Past 5 Years
-103.71M
Minimum
Mar 2024
-25.79M
Maximum
Jun 2019
-67.58M
Average
-71.19M
Median
Free Cash Flow Benchmarks
Phio Pharmaceuticals Corp | -10.05M |
Ocular Therapeutix Inc | -87.11M |
Scholar Rock Holding Corp | -152.02M |
RAPT Therapeutics Inc | -106.00M |
Pyxis Oncology Inc | -67.14M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -33.60M |
Cash from Investing (Quarterly) | -5.322M |
Free Cash Flow Per Share (Quarterly) | -0.1683 |
Free Cash Flow Yield | -54.84% |